Retraction
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Paper Information
Record ID:
34229
Author(s):
Journal:
Publication Date:
March 21, 2014
Retraction Date:
October 08, 2021
(4.1 years years ago)
Subjects:
Institutions:
- Vascular Biology Research Institute, Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China
- Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, MI 48109, USA
- Department of Histology and Embryology, Key Laboratory for Regenerative Medicine of the Ministry of Education, Medical College of Jinan University, Guangzhou 510632, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
IOS Publishing (Institute of Science Publishing)
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.7150/ijbs.66938Additional Notes:
see also: https://pubpeer.com/publications/685EA6A9395896242B9580E896D8CC
Citations (44)
44
Total Citations12
Post-Retraction(27.3%)
30
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
7
Within 1 year
3
After 2+ years
1242
Days since retraction (latest)
Paper citing Andrographolide Suppress Tumor Growth by Inhibitin...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Andrographolide Suppress Tumor Growth by Inhibitin...
Unknown Authors
Unknown Journal
Published: Unknown
Diterpenes: Nature’s Hidden Gems of Immunomodulation
Jonas S. Almeida, André Correa de Oliveira, Carlos Eduardo de Castro Alves et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2025
1242 days after retraction
Innovative anticancer molecule andrographolide: a concise review of its pharmacological targets
Venu Sharma, Gourav Kumar, Parveen Kumar et al. (5 authors)
Natural Product Research
Published: Jan 2025
1191 days after retraction
ADDITIVE CYTOTOXIC EFFECT OF CISPLATIN AND ANDROGRAPHIS PANICULATA EXTRACT THROUGH THE MODULATION OF APOPTOTIC MARKERS, CYCLIN-D AND VEGF EXPRESSIONS IN SKOV3 OVARIAN CANCER CELL LINE
FARA VITANTRI DIAH, Nuzli Fahdia Mazfufah, Wawaimuli Arozal et al. (8 authors)
International Journal of Applied Pharmaceutics
Open Access
Published: Jan 2025
1187 days after retraction
Dysregulation of inflammasome activation in glioma
JeongMin Sim, JeongMan Park, Jong‐Seok Moon et al. (4 authors)
Cell Communication and Signaling
Open Access
Published: Sep 2023
11 citations
11 citations
710 days after retraction
Andrographolide protects against doxorubicin-and arsenic trioxide-induced toxicity in cardiomyocytes
Leila Safaeian, Fatemeh Shafiee, Samira Haghighatnazar
Molecular Biology Reports
Published: Nov 2022
5 citations
5 citations
394 days after retraction
Andrographolide Protects Against Doxorubicin- and Arsenic Trioxide-Induced Toxicity in Cardiomyocytes
Leila Safaeian, Fatemeh Shafiee, Samira Haghighatnazar
Research Square (Research Square)
Published: Aug 2022
325 days after retraction
Real-Time Monitoring the Cytotoxic Effect of Andrographolide on Human Oral Epidermoid Carcinoma Cells
Heng-Yi Liao, Chun-Chung Huang, Shih‐Chi Chao et al. (7 authors)
Biosensors
Open Access
Published: May 2022
7 citations
7 citations
210 days after retraction
Downregulation of miR-760 Causes Human Intervertebral Disc Degeneration by Targeting the MyD88/Nuclear Factor-Kappa B Signaling Pathway
Xueliang Cui, Yanan Li, Jun-Ping Bao et al. (5 authors)
Frontiers in Bioengineering and Biotechnology
Open Access
Published: Apr 2022
4 citations
4 citations
185 days after retraction
Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
Sajad Fakhri, Seyed Zachariah Moradi, Akram Yarmohammadi et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Mar 2022
28 citations
28 citations
144 days after retraction
Colchicine and Andrographolide as Natural Immunomodulators
S. Yasri, Viroj Wiwanitkit
Unknown Journal
Published: Jan 2022
85 days after retraction
Synergy and network pharmacology—Establishing the efficacy of herbal medicine
Pulok K. Mukherjee, Subhadip Banerjee, Amit Kar et al. (7 authors)
Elsevier eBooks
Published: Jan 2022
2 citations
2 citations
85 days after retraction
Andrographolide: A review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches
Bin Zeng, Ailing Wei, Qiang Zhou et al. (9 authors)
Phytotherapy Research
Published: Nov 2021
100 citations
100 citations
47 days after retraction
Plant Derived Immunomodulators; A Critical Review
Akey Krishna Swaroop, MVNL Chaitanya, Meena Shanmugam et al. (6 authors)
Advanced Pharmaceutical Bulletin
Open Access
Published: Oct 2021
13 citations
13 citations
6 days before retraction
Study on the Antitumor Effect and Glycolysis of Andrographolide in Anaplastic Thyroid Carcinoma
Ke Yang, Ke Wu, Jianguo Feng et al. (6 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jul 2021
2 citations
2 citations
86 days before retraction
Biological properties of andrographolide, an active ingredient of Andrographis Paniculata: a narrative review
Václav Větvička, Luca Vannucci
Annals of Translational Medicine
Open Access
Published: Jul 2021
51 citations
51 citations
99 days before retraction
Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway
Junchen Li, Lixun Huang, Zinan He et al. (16 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Jun 2021
33 citations
33 citations
107 days before retraction
Tetramethylpyrazine Improves Cognitive Function of Alzheimer’s Disease Mice by Regulating SSTR4 Ubiquitination
Guohu Weng, Bo Zhou, Tao Liu et al. (5 authors)
Drug Design Development and Therapy
Open Access
Published: May 2021
17 citations
17 citations
130 days before retraction
Anticancer potential of andrographolide from Andrographis paniculata (Burm.f.) Nees and its mechanisms of action
Zoya Malik, Rabea Parveen, Bushra Parveen et al. (9 authors)
Journal of Ethnopharmacology
Published: Feb 2021
66 citations
66 citations
231 days before retraction
Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and In Vitro Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical Cancer
Akbar Pasha, Divya Vishambhar Kumbhakar, Doneti Ravinder et al. (14 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jan 2021
29 citations
29 citations
280 days before retraction
Natural Compounds Extracted from Medicinal Plants and Their Immunomodulatory Activities
Vinod Kumar Gurjar, Dilipkumar Pal
Advanced structured materials
Published: Dec 2020
18 citations
18 citations
298 days before retraction
The Natural Flavonoid Naringenin Inhibits the Cell Growth of Wilms Tumor in Children by Suppressing TLR4/NF-κB Signaling
Hongtao Li, Peng Chen, Lei Chen et al. (4 authors)
Anti-Cancer Agents in Medicinal Chemistry
Published: Aug 2020
2 citations
2 citations
413 days before retraction
Electrochemical Assessment of Anticancer Compounds on the Human Tongue Squamous Carcinoma Cells
Chun-Chung Huang, Tse-Hua Tung, Chien-Chu Huang et al. (8 authors)
Sensors
Open Access
Published: May 2020
15 citations
15 citations
521 days before retraction
microRNA-216a protects against human retinal microvascular endothelial cell injury in diabetic retinopathy by suppressing the NOS2/JAK/STAT axis
Yong Liu, Jianhe Xiao, Yanyan Zhao et al. (7 authors)
Experimental and Molecular Pathology
Published: Apr 2020
20 citations
20 citations
533 days before retraction
Andrographolide induces apoptosis in human osteosarcoma cells via the ROS/JNK pathway
Shengdong Wang, Hengyuan Li, Shi Chen et al. (8 authors)
International Journal of Oncology
Open Access
Published: Mar 2020
40 citations
40 citations
557 days before retraction
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum
Qianqian Zhang, Yi Ding, Lei Yan et al. (11 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2020
646 days before retraction
Inflammasome inhibitors: promising therapeutic approaches against cancer
Shengchao Xu, Xizhe Li, Yuanqi Liu et al. (6 authors)
Journal of Hematology & Oncology
Open Access
Published: Jun 2019
75 citations
75 citations
835 days before retraction
Andrographolide Enhances TRAIL-Induced Apoptosis via <i>p53</i>-Mediated Death Receptors Up-Regulation and Suppression of the NF-кB Pathway in Bladder Cancer Cells
Yuyou Deng, Ran Bi, Haoran Guo et al. (7 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2019
42 citations
42 citations
1011 days before retraction
Andrographolide mitigates IL‑1β‑induced human nucleus pulposus cells degeneration through the TLR4/MyD88/NF‑κB signaling pathway
Lilian Zhang, Qi Chen, Haoli Wang et al. (5 authors)
Molecular Medicine Reports
Open Access
Published: Oct 2018
19 citations
19 citations
1079 days before retraction
Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer
Vinita Mishra, Chandramani Pathak
International Journal of Biological Macromolecules
Published: Oct 2018
35 citations
35 citations
1080 days before retraction
Andrographolide induces degradation of mutant p53 via activation of Hsp70
Hirofumi Sato, Masatsugu Hiraki, Takushi Namba et al. (7 authors)
International Journal of Oncology
Open Access
Published: May 2018
19 citations
19 citations
1235 days before retraction
Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer
Muhammad Torequl Islam, Eunüs S. Ali, Shaikh Jamal Uddin et al. (24 authors)
Cancer Letters
Published: Feb 2018
172 citations
172 citations
1332 days before retraction
Anticancer Potential of Andrographolide, a Diterpenoid Lactone from Andrographis paniculata: A Nature’s Treasure for Chemoprevention and Therapeutics
Imran Khan, Mohd Aslam Yusuf, Irfan Ahmad Ansari et al. (4 authors)
Springer eBooks
Published: Jan 2018
5 citations
5 citations
1376 days before retraction
Andrographolide inhibits influenza A virus-induced inflammation in a murine model through NF-κB and JAK-STAT signaling pathway
Yi Ding, Lizhu Chen, Wenjiao Wu et al. (6 authors)
Microbes and Infection
Published: Sep 2017
94 citations
94 citations
1491 days before retraction
Andrographolide induces apoptotic and non-apoptotic death and enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in gastric cancer cells
Sung‐Chul Lim, Ho Jong Jeon, Keun Hong Kee et al. (6 authors)
Oncology Letters
Open Access
Published: Mar 2017
31 citations
31 citations
1656 days before retraction
Andrographolide Inhibits Inflammatory Cytokines Secretion in LPS-Stimulated RAW264.7 Cells through Suppression of NF-<i>κ</i>B/MAPK Signaling Pathway
Li Yu, Shengnan He, Jishun Tang et al. (12 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2017
75 citations
75 citations
1741 days before retraction
Andrographolide Inhibits Angiogenesis by Inhibiting the Mir-21-5p/TIMP3 Signaling Pathway
Jianwei Dai, Yuyin Lin, Youfa Duan et al. (8 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2017
43 citations
43 citations
1741 days before retraction
Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis
Dhiraj Kumar, Santosh Kumar, Mahadeo Gorain et al. (10 authors)
Journal of Investigative Dermatology
Open Access
Published: Jul 2016
74 citations
74 citations
1896 days before retraction
Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment
Aditi Banerjee, Hafiz Ahmed, Peixin Yang et al. (5 authors)
Oncotarget
Open Access
Published: May 2016
86 citations
86 citations
1982 days before retraction
Andrographolide suppresses thymic stromal lymphopoietin in phorbol myristate acetate/calcium ionophore A23187-activated mast cells and 2,4-dinitrofluorobenzene-induced atopic dermatitis-like mice model
Chunxiao Li, Hua-guo Li, Hui Zhang et al. (10 authors)
Drug Design Development and Therapy
Open Access
Published: Feb 2016
14 citations
14 citations
2076 days before retraction
Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway
Hui Gao, Jianrong Wang
Molecular Medicine Reports
Open Access
Published: Dec 2015
45 citations
45 citations
2117 days before retraction
Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways
Tao Wang, Qian Liu, Lin Zhou et al. (9 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2015
21 citations
21 citations
2152 days before retraction
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
Ibrahim Jantan, Waqas Ahmad, Syed Nasir Abbas Bukhari
Frontiers in Plant Science
Open Access
Published: Aug 2015
379 citations
379 citations
2236 days before retraction
Quick Stats
Total Citations:
44
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025